Last reviewed · How we verify
NCT07211204
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
NA trial testing Physical examination in Atypical Squamous Cell of Undetermined Significance. Withdrawn.
27 February 2026
Quick facts
| Lead sponsor | Timser SAPI de CV |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | screening |
| Start date | 27 February 2026 |
| Primary completion | 27 February 2026 |
| Estimated completion | 27 February 2026 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Physical examination
- Liquid-based cytology
- Molecular screening
- HPV DNA test
- Colposcopy
- Histopathology
Conditions studied
- Atypical Squamous Cell of Undetermined Significance — all drugs for Atypical Squamous Cell of Undetermined Significance →
- ASC-US — all drugs for ASC-US →
- Atypical Glandular Cells of Uncertain Significance — all drugs for Atypical Glandular Cells of Uncertain Significance →
- AGUS — all drugs for AGUS →
Sponsor
Timser SAPI de CV — full company profile →
Who can join
Adults 18 to 85, female only, with Atypical Squamous Cell of Undetermined Significance or ASC-US. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study compares the efficacy of cytology (Pap smear) with the molecular screening in their ability to detect reactive cellular changes in the cervix among an open population
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07211204
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical examination
Trials testing the same drug.
- NCT06555757 — Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation · not yet recruiting
- NCT05858021 — COrSIcA: Disease Measurement · unknown
- NCT06161142 — Characteristics of Hypophosphatasia in Adult Patients in Rheumatology · unknown
- NCT06060925 — Imaging Biomarkers for Myofascial Pain · completed
- NCT05037162 — Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07211204 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Timser SAPI de CV
- Last refreshed: 3 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07211204.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing